Express News | The USA Biological Security Act was not included in the CR bill.

BreakingsDec 18 15:53

ALPHAMAB-B (09966.HK): ADC frontier exploration differentiated development, a major variety covering multiple subtypes of breast cancer is about to be realized.

The company has a leading in-house technology platform that continuously iterates, including single-domain antibody platforms, dual antibody platforms, glycosylated point-coupled platforms (ADC), subcutaneous high-concentration formulation platforms, and the latest developed dual toxin ADC platform.

ZhongtaiDec 16 00:00

The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!

Industry pessimistic expectations may improve.

Gelonghui FinanceDec 9 12:10

How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.

① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.

cls.cnDec 8 16:48

Buyback collection on November 29 | Tencent, AIA and others repurchase shares, with Tencent spending 0.7 billion Hong Kong dollars.

According to a document disclosed by hkex on December 2, $tencent (00700.HK)$ and $aia (01299.HK)$ repurchased shares.① $tencent (00700.HK)$ repurchased 1.76 million ordinary shares on November 29, involving an amount of 0.7 billion Hong Kong dollars, with a repurchase price ranging from 402.4 Hong Kong dollars to 395 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.197 billion shares, accounting for 2.091% of the number of issued shares at the time the ordinary resolution was passed.② $aia (01299.HK)$ on November 29

Futu NewsDec 2 09:30

CSPC Pharmaceuticals Group Limited -B(09966) spent 2.2756 million Hong Kong dollars to repurchase 0.6 million shares on November 29.

Corning Pharmaceutical-B (09966) announced that on November 29, 2024, the company invested 227...

Zhitong FinanceNov 29 20:33